Literature DB >> 1324311

Human papillomavirus-associated lesions of the vagina and cervix. Treatment with a laser and topical 5-fluorouracil.

M Brodman1, P Dottino, F Friedman, D Heller, I Bleiweiss, R Sperling.   

Abstract

Twenty women with cervical and vaginal human papillomavirus-associated lesions were treated with CO2 laser ablation followed by eight weekly applications of 5-fluorouracil. Viral subtyping in a majority of patients and histology were obtained before and after treatment. After treatment 88% (15 of 17) had normal vaginal biopsies, and 59% (10 of 17) had normal cervical biopsies. There were no treatment failures with subtype 6/11 infection of the cervix or vagina. All the failures were with viral subtypes 16/18 and 31/35/51. The protocol was effective in treating patients with cervical and vaginal human papillomavirus-associated lesions.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1324311

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  4 in total

Review 1.  The incidence of human papillomavirus infection following treatment for cervical neoplasia: a systematic review.

Authors:  Anne F Rositch; Heidi M Soeters; Tabatha N Offutt-Powell; Bradford S Wheeler; Sylvia M Taylor; Jennifer S Smith
Journal:  Gynecol Oncol       Date:  2014-01-07       Impact factor: 5.482

Review 2.  5-FU for genital warts in non-immunocompromised individuals.

Authors:  Claudio S Batista; Alvaro N Atallah; Humberto Saconato; Edina Mk da Silva
Journal:  Cochrane Database Syst Rev       Date:  2010-04-14

3.  Topical therapies for the treatment of anal high-grade squamous intraepithelial lesions.

Authors:  Christina Megill; Timothy Wilkin
Journal:  Semin Colon Rectal Surg       Date:  2017-04-26

4.  A randomized, double-blind, placebo-controlled trial of 5-fluorouracil for the treatment of cervicovaginal human papillomavirus.

Authors:  M M Holmes; S H Weaver; S T Vermillion
Journal:  Infect Dis Obstet Gynecol       Date:  1999
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.